Centerstone Of Florida, Inc. | |
2020 26th Ave E Bradenton FL 34208-7753 | |
(941) 782-4600 | |
(941) 782-4601 |
Full Name | Centerstone Of Florida, Inc. |
---|---|
Speciality | Clinic/Center |
Location | 2020 26th Ave E, Bradenton, Florida |
Authorized Official Name and Position | Sean Gingras (REGIONAL FINANCE OFFICER) |
Authorized Official Contact | 9417824299 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Centerstone Of Florida, Inc. P.o. Box 9478 Bradenton FL 34206-9478 Ph: (941) 782-4299 | Centerstone Of Florida, Inc. 2020 26th Ave E Bradenton FL 34208-7753 Ph: (941) 782-4600 |
NPI Number | 1144251638 |
---|---|
Provider Enumeration Date | 07/05/2006 |
Last Update Date | 11/27/2023 |
Certification Date | 11/27/2023 |
Medicare PECOS PAC ID | 2668468596 |
---|---|
Medicare Enrollment ID | O20040424000001 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1144251638 | NPI | - | NPPES |
260859600 | Medicaid | FL | |
004469304 | Medicaid | FL | |
060280905 | Medicaid | FL | |
060280900 | Medicaid | FL | |
060280901 | Medicaid | FL | |
060280910 | Medicaid | FL | |
004469301 | Medicaid | FL | |
004469303 | Medicaid | FL | |
004469305 | Medicaid | FL |
Provider Name | Ann L Burke |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1598742884 PECOS PAC ID: 9032273743 Enrollment ID: I20090126000046 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Margarida M Soares Lance |
---|---|
Provider Type | Practitioner - Anesthesiology |
Provider Identifiers | NPI Number: 1558315093 PECOS PAC ID: 4486701505 Enrollment ID: I20090407000349 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Ranjay Halder |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1679779573 PECOS PAC ID: 4688867971 Enrollment ID: I20101019001031 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Ilona D Reuter |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1275528994 PECOS PAC ID: 7719172592 Enrollment ID: I20101108000466 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jose T Zaglul |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1225024763 PECOS PAC ID: 8123213212 Enrollment ID: I20101115001045 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Deborah Lasebny |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1134227085 PECOS PAC ID: 9133210164 Enrollment ID: I20101122000701 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Deborah L Lorshbough |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1508883380 PECOS PAC ID: 5294918876 Enrollment ID: I20110318000486 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Patricia A Sauter |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1821201393 PECOS PAC ID: 1153505920 Enrollment ID: I20110404000311 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Robert K Boxley |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1871584045 PECOS PAC ID: 3577747880 Enrollment ID: I20110412000226 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Luis J Jasa |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1366534836 PECOS PAC ID: 1052203650 Enrollment ID: I20110614000708 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jesus E. Linares |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1144384108 PECOS PAC ID: 6800064064 Enrollment ID: I20110714000634 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | John B Hodgens |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1710106521 PECOS PAC ID: 0446423180 Enrollment ID: I20111025000824 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | David Nathan Greenblum |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1467462713 PECOS PAC ID: 6002089992 Enrollment ID: I20111122000580 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Peter Sukin |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1932178787 PECOS PAC ID: 9638075120 Enrollment ID: I20120501000486 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Paul H Wurst |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1366448615 PECOS PAC ID: 0840297966 Enrollment ID: I20120524000291 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Daniel H Gessesse |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1417112293 PECOS PAC ID: 2961643416 Enrollment ID: I20130725000142 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Luretta S Snyder |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1407260698 PECOS PAC ID: 9436376381 Enrollment ID: I20140816000168 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Marco A Rabines |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1780833038 PECOS PAC ID: 5597912055 Enrollment ID: I20140828001414 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Waleska Acevedo |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1871858175 PECOS PAC ID: 0840410635 Enrollment ID: I20140929002493 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Ismely Shannon |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1154640381 PECOS PAC ID: 6608098132 Enrollment ID: I20141117000870 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Shashidhar Reddy Sheshani |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1588732432 PECOS PAC ID: 7214189869 Enrollment ID: I20141201001930 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Ann Bernice Hart |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1548697626 PECOS PAC ID: 9032432471 Enrollment ID: I20141216001313 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Rodolfo E Reni |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1619935277 PECOS PAC ID: 2163435231 Enrollment ID: I20141222001540 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Dennis K Rhyne |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1316927528 PECOS PAC ID: 8426224734 Enrollment ID: I20150528002865 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Karen S Campbell |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1265873178 PECOS PAC ID: 2365665809 Enrollment ID: I20151111002083 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Lucille Fernandez |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1154566859 PECOS PAC ID: 3577854140 Enrollment ID: I20160629001228 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Brock Hollett |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1528475324 PECOS PAC ID: 9335433952 Enrollment ID: I20160804001562 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Pamela Denison |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1376098673 PECOS PAC ID: 9335436625 Enrollment ID: I20160930000440 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Kenneth Greenwood |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1275637951 PECOS PAC ID: 7810893617 Enrollment ID: I20161115001984 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Joshua Stephens |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1972730612 PECOS PAC ID: 2860632908 Enrollment ID: I20170525001883 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Janet Taylor |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1154418994 PECOS PAC ID: 3971561994 Enrollment ID: I20170711002057 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Briton Chan |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1124407994 PECOS PAC ID: 8426329293 Enrollment ID: I20170814000534 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jeffrey Hamblin |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1306823851 PECOS PAC ID: 5991738171 Enrollment ID: I20171009003334 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Hallie Rebecca Talov |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1295089696 PECOS PAC ID: 7315295086 Enrollment ID: I20180813001989 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Luke T Chiou |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1063863546 PECOS PAC ID: 0244580140 Enrollment ID: I20180913000650 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jena L Lieb |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1710455936 PECOS PAC ID: 8022355593 Enrollment ID: I20190123000887 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Rebecca Edwards |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1659925089 PECOS PAC ID: 1254660715 Enrollment ID: I20190909001287 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Bernadette Frye |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1790325843 PECOS PAC ID: 0042647745 Enrollment ID: I20200218002822 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jacqueline Hostetter |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1790098671 PECOS PAC ID: 8123214541 Enrollment ID: I20200506001743 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Kathryn A Pinkston |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1235753674 PECOS PAC ID: 3274953260 Enrollment ID: I20201013001165 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Emmanuella Armand |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1447863345 PECOS PAC ID: 6406267095 Enrollment ID: I20201203001475 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Meghan Bruen |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1568072882 PECOS PAC ID: 3577968098 Enrollment ID: I20210823000416 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Maria Lana Barnes |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1871128363 PECOS PAC ID: 8729485891 Enrollment ID: I20210916002750 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Frank Escobar Roger |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1245268713 PECOS PAC ID: 1850394859 Enrollment ID: I20211022002272 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Eileen M Burchby |
---|---|
Provider Type | Practitioner - Addiction Medicine |
Provider Identifiers | NPI Number: 1407808744 PECOS PAC ID: 3577465889 Enrollment ID: I20211118003123 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Edsaida Ortiz-santiago |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1518553171 PECOS PAC ID: 3173912615 Enrollment ID: I20211122002955 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Deanna Lomax |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1215399050 PECOS PAC ID: 8123358298 Enrollment ID: I20220125000688 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Chelsea Anne Noble |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1336496736 PECOS PAC ID: 5890180699 Enrollment ID: I20220314001703 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Daphne Louise Weeks |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1750981890 PECOS PAC ID: 6901292143 Enrollment ID: I20220415000158 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jacklyn P Stump |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1023775400 PECOS PAC ID: 1759778939 Enrollment ID: I20220419001433 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jacqueline Ann Nixon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1811567217 PECOS PAC ID: 3870980766 Enrollment ID: I20220422002191 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Casey Jane Hoffman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1548833890 PECOS PAC ID: 9133516073 Enrollment ID: I20220425001118 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Victoria Kastor |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1790314318 PECOS PAC ID: 1254719784 Enrollment ID: I20220611000262 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Philip Atanmo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1376123018 PECOS PAC ID: 2365822657 Enrollment ID: I20220705000505 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Beth Hicks |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1962893776 PECOS PAC ID: 8628398625 Enrollment ID: I20221118000183 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Karen Gooden |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1821707936 PECOS PAC ID: 9436529682 Enrollment ID: I20230104000090 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Jennifer Reali |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1174224836 PECOS PAC ID: 2567836893 Enrollment ID: I20230328000833 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Khydine Senior |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1770281420 PECOS PAC ID: 1557725843 Enrollment ID: I20230920001022 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Kayla Paser |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1598448615 PECOS PAC ID: 8729435458 Enrollment ID: I20231116003080 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Barbara Angela Morelli |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1952381998 PECOS PAC ID: 3173970811 Enrollment ID: I20231116003643 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Chelsea Walker |
---|---|
Provider Type | Practitioner - Marriage And Family Therapist |
Provider Identifiers | NPI Number: 1437842937 PECOS PAC ID: 0143678821 Enrollment ID: I20231120001591 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Deirdre Michelle Guilloton |
---|---|
Provider Type | Practitioner - Marriage And Family Therapist |
Provider Identifiers | NPI Number: 1679088686 PECOS PAC ID: 3375991961 Enrollment ID: I20231120002868 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Patricia Lynn Normile |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1538460910 PECOS PAC ID: 6103274758 Enrollment ID: I20231121001552 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Alexis Kalish |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1912694241 PECOS PAC ID: 4688022247 Enrollment ID: I20231121001858 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Tari Ann Allan |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1417934936 PECOS PAC ID: 4981052206 Enrollment ID: I20231128001232 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Monica Jean Davis |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1619582418 PECOS PAC ID: 1153779319 Enrollment ID: I20231128003006 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Iris Curry |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1053645077 PECOS PAC ID: 5991153843 Enrollment ID: I20231202000782 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Amanda Merkel |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1588118913 PECOS PAC ID: 1759730054 Enrollment ID: I20231212002810 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Richard Lewis Whitton |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1124326632 PECOS PAC ID: 2264883222 Enrollment ID: I20240104000937 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Alexandra Riley Servia |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1992497911 PECOS PAC ID: 8325499221 Enrollment ID: I20240104002682 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Eri Conklin |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1558644468 PECOS PAC ID: 4688025596 Enrollment ID: I20240104003091 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Natalia Aviles-otero |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1588446199 PECOS PAC ID: 3274984109 Enrollment ID: I20240104003750 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | M. M. Trzeciak-kerr |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1972658177 PECOS PAC ID: 3375994189 Enrollment ID: I20240105002019 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Provider Name | Corina M Forte |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1063057263 PECOS PAC ID: 9436594637 Enrollment ID: I20240227004302 |
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
News Archive
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
A Mayo Clinic allergist and his colleagues have announced that they are revising the old classification of asthma patients by disease severity to determine treatment, and moving to a new expectation for all asthma patients: excellent symptom control.
The National Institutes of Health (NIH) has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody "cocktail" to fight the deadly Ebola virus.
The National Comprehensive Cancer Network has been awarded two individual $2 million grants from GlaxoSmithKline to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors.
New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.
› Verified 7 days ago
Fullness Of Life Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1103 9th Ave W, Bradenton, FL 34205 Phone: 941-800-1513 | |
Clarea, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13062 Bliss Loop, Bradenton, FL 34211 Phone: 941-248-6987 Fax: 217-787-3232 | |
Orlando Maldonado, Md, Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 407 6th Ave E, Bradenton, FL 34208 Phone: 941-749-7997 | |
Denise K. Gross, Psy.d., Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6015 111th St E, Bradenton, FL 34211 Phone: 941-756-0292 Fax: 941-756-0161 | |
Abdul Nadeem, M.d.llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7015 Gosling Ter, Bradenton, FL 34203 Phone: 941-313-0084 | |
1st Applied Behavioral Associates, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12907 Bliss Loop, Bradenton, FL 34211 Phone: 941-229-1029 | |
Pamela S Bowyer Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4802 26th St W Ste C, Bradenton, FL 34207 Phone: 941-752-7773 Fax: 941-752-7774 |